Literature DB >> 11544340

The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent.

D C Hooper1, R B Kean, G S Scott, S V Spitsin, T Mikheeva, K Morimoto, M Bette, A M Röhrenbeck, B Dietzschold, E Weihe.   

Abstract

We have recently demonstrated that increased blood-CNS barrier permeability and CNS inflammation in a conventional mouse model of experimental allergic encephalomyelitis are dependent upon the production of peroxynitrite (ONOO(-)), a product of the free radicals NO* and superoxide (O2*(-)). To determine whether this is a reflection of the physiological contribution of ONOO(-) to an immune response against a neurotropic pathogen, we have assessed the effects on adult rats acutely infected with Borna disease virus (BDV) of administration of uric acid (UA), an inhibitor of select chemical reactions associated with ONOO(-). The pathogenesis of acute Borna disease in immunocompetent adult rats results from the immune response to the neurotropic BDV, rather than the direct effects of BDV infection of neurons. An important stage in the BDV-specific neuroimmune response is the invasion of inflammatory cells into the CNS. UA treatment inhibited the onset of clinical disease, and prevented the elevated blood-brain barrier permeability as well as CNS inflammation seen in control-treated BDV-infected rats. The replication and spread of BDV in the CNS were unchanged by the administration of UA, and only minimal effects on the immune response to BDV Ags were observed. These results indicate that the CNS inflammatory response to neurotropic virus infection is likely to be dependent upon the activity of ONOO(-) or its products on the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544340     DOI: 10.4049/jimmunol.167.6.3470

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice.

Authors:  Aaron L Olsen; John D Morrey; Donald F Smee; Robert W Sidwell
Journal:  Antiviral Res       Date:  2006-12-20       Impact factor: 5.970

2.  Animal models of CNS viral disease: examples from borna disease virus models.

Authors:  Marylou V Solbrig
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-24

3.  Uric acid protects against secondary damage after spinal cord injury.

Authors:  Gwen S Scott; Salvatore Cuzzocrea; Tiziana Genovese; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

4.  Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury.

Authors:  Robin J Goody; Cristen C Hoyt; Kenneth L Tyler
Journal:  Exp Neurol       Date:  2005-10       Impact factor: 5.330

5.  Dual Role of Toll-Like Receptor 7 in the Pathogenesis of Rabies Virus in a Mouse Model.

Authors:  Zhaochen Luo; Lei Lv; Yingying Li; Baokun Sui; Qiong Wu; Yachun Zhang; Jie Pei; Mingming Li; Ming Zhou; D Craig Hooper; Zhen F Fu; Ling Zhao
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

6.  Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine.

Authors:  Natalia Pogrebnyak; Maxim Golovkin; Vyacheslav Andrianov; Sergei Spitsin; Yuriy Smirnov; Richard Egolf; Hilary Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-14       Impact factor: 11.205

7.  Therapeutic immune clearance of rabies virus from the CNS.

Authors:  D Craig Hooper; Anirban Roy; Rhonda B Kean; Timothy W Phares; Darryll A Barkhouse
Journal:  Future Virol       Date:  2011-03-01       Impact factor: 1.831

8.  Differential expression of growth factors at the cellular level in virus-infected brain.

Authors:  Mikhail Prosniak; Anna Zborek; Gwen S Scott; Anirban Roy; Timothy W Phares; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-07       Impact factor: 11.205

9.  Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.

Authors:  Marzena J Fabis; Timothy W Phares; Rhonda B Kean; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

10.  Disruption of IFN-gamma- mediated antiviral activity in neurons: the role of cannabinoids.

Authors:  R Antonio Herrera; Joseph H Oved; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.